These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9632359)

  • 1. Three-dimensional quantitative structure-activity relationship study of nonsteroidal estrogen receptor ligands using the comparative molecular field analysis/cross-validated r2-guided region selection approach.
    Sadler BR; Cho SJ; Ishaq KS; Chae K; Korach KS
    J Med Chem; 1998 Jun; 41(13):2261-7. PubMed ID: 9632359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of estradiol-17 beta: a 3D QSAR study.
    Wiese TE; Polin LA; Palomino E; Brooks SC
    J Med Chem; 1997 Oct; 40(22):3659-69. PubMed ID: 9357533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional model of nonsteroidal estrogen receptor ligand binding/electron topological method.
    Guzel Y; Sivritas K
    Arzneimittelforschung; 2004; 54(6):348-54. PubMed ID: 15281621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of estrogen receptor alpha and beta subtypes based on comparative molecular field analysis (CoMFA).
    Xing L; Welsh WJ; Tong W; Perkins R; Sheehan DM
    SAR QSAR Environ Res; 1999; 10(2-3):215-37. PubMed ID: 10491851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CoMFA and docking study of novel estrogen receptor subtype selective ligands.
    Wolohan P; Reichert DE
    J Comput Aided Mol Des; 2003; 17(5-6):313-28. PubMed ID: 14635724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D-QSAR study of bis-azaaromatic quaternary ammonium analogs at the blood-brain barrier choline transporter.
    Geldenhuys WJ; Lockman PR; Nguyen TH; Van der Schyf CJ; Crooks PA; Dwoskin LP; Allen DD
    Bioorg Med Chem; 2005 Jul; 13(13):4253-61. PubMed ID: 15878282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin receptor ligands: synthesis of new melatonin derivatives and comprehensive comparative molecular field analysis (CoMFA) study.
    Mor M; Rivara S; Silva C; Bordi F; Plazzi PV; Spadoni G; Diamantini G; Balsamini C; Tarzia G; Fraschini F; Lucini V; Nonno R; Stankov BM
    J Med Chem; 1998 Sep; 41(20):3831-44. PubMed ID: 9748358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the structural requirements of the receptor-binding affinity of diphenolic azoles to estrogen receptors alpha and beta by three-dimensional quantitative structure-activity relationship and structure-activity relationship analysis.
    Demyttenaere-Kovatcheva A; Cronin MT; Benfenati E; Roncaglioni A; Lopiparo E
    J Med Chem; 2005 Dec; 48(24):7628-36. PubMed ID: 16302803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D-QSAR analysis of conformationally constrained diacylglycerol (DAG) analogues as potent protein kinase C (PK-C) ligands.
    Kim SY; Lee J
    Bioorg Med Chem; 2004 May; 12(10):2639-44. PubMed ID: 15110845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D QSAR comparative molecular field analysis on nonsteroidal farnesoid X receptor activators.
    Honório KM; Garratt RC; Polikarpov I; Andricopulo AD
    J Mol Graph Model; 2007 Mar; 25(6):921-7. PubMed ID: 17055759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor.
    Zhang H; Li H; Ma Q
    J Mol Graph Model; 2007 Jul; 26(1):226-35. PubMed ID: 17208024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative molecular field analysis of hydantoin binding to the neuronal voltage-dependent sodium channel.
    Brown ML; Zha CC; Van Dyke CC; Brown GB; Brouillette WJ
    J Med Chem; 1999 May; 42(9):1537-45. PubMed ID: 10229624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor agents. 163. Three-dimensional quantitative structure-activity relationship study of 4'-O-demethylepipodophyllotoxin analogs using the modified CoMFA/q2-GRS approach.
    Cho SJ; Tropsha A; Suffness M; Cheng YC; Lee KH
    J Med Chem; 1996 Mar; 39(7):1383-95. PubMed ID: 8691468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and chemical basis for enhanced affinity and potency for a large series of estrogen receptor ligands: 2D and 3D QSAR studies.
    Salum Lde B; Polikarpov I; Andricopulo AD
    J Mol Graph Model; 2007 Sep; 26(2):434-42. PubMed ID: 17349808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
    van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH
    J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional quantitative structure-activity relationship of melatonin receptor ligands: a comparative molecular field analysis study.
    Sicsic S; Serraz I; Andrieux J; Brémont B; Mathé-Allainmat M; Poncet A; Shen S; Langlois M
    J Med Chem; 1997 Feb; 40(5):739-48. PubMed ID: 9057860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative structure-activity relationship modeling of dopamine D(1) antagonists using comparative molecular field analysis, genetic algorithms-partial least-squares, and K nearest neighbor methods.
    Hoffman B; Cho SJ; Zheng W; Wyrick S; Nichols DE; Mailman RB; Tropsha A
    J Med Chem; 1999 Aug; 42(17):3217-26. PubMed ID: 10464009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CoMFA and CoMSIA 3D QSAR analysis on N1-arylsulfonylindole compounds as 5-HT6 antagonists.
    Doddareddy MR; Cho YS; Koh HY; Pae AN
    Bioorg Med Chem; 2004 Aug; 12(15):3977-85. PubMed ID: 15246074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D-QSAR studies of arylpyrazole antagonists of cannabinoid receptor subtypes CB1 and CB2. A combined NMR and CoMFA approach.
    Chen JZ; Han XW; Liu Q; Makriyannis A; Wang J; Xie XQ
    J Med Chem; 2006 Jan; 49(2):625-36. PubMed ID: 16420048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.